SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Sobi’s pozdeutinurad lowers urate levels in Phase 3 gout study

Sobi said pozdeutinurad lowers urate levels in a Phase 3 gout study.

SquawkNews Desk 1 updates Updated Nov 03, 2026, 07:13 AM UTC

Story updates

07:13:56 AM UTC
SquawkNews
Sobi's pozdeutinurad lowers serum urate levels in Phase 3 gout trial Sobi will present six gout

Related stories

Waters Acquires Mobilion Systems Waters said it acquired Mobilion Systems, adding ion-mobility separation technology to its mass spectrometry portfolio. M impact | EQUITY | Nov 03, 2026, 10:56 AM UTC Remedy Entertainment Swings to EUR 600,000 Q3 EBIT Profit Q3 revenue more than tripled year on year to EUR 39.6 million. M impact | EQUITY | Nov 03, 2026, 10:56 AM UTC Remedyn Q3 Operating Profit Turns Positive Remedyn Q3 2026 operating profit turned positive year over year, while revenue more than tripled. M impact | EQUITY | Nov 03, 2026, 10:56 AM UTC Kia America October Sales Rise 16% Kia America said it achieved record overall and retail sales for a sixth consecutive month, driven by demand for electrified vehicles and hybrids. It sold 80,008 vehicles. M impact | EQUITY | Nov 03, 2026, 10:54 AM UTC Advanced Info Service Reports Quarterly Revenue of 58.06 Billion Baht M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC Cosmo First Q2 Consolidated Revenue From Operations INR 13,878.6 Million M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC